According to FutureWise analysis the market for Antiplatelet in 2023 is US$ 3.97 billion, and is expected to reach US$ 5.61 billion by 2031 at a CAGR of 4.42%.
Antiplatelets are a class of medications that prevent platelets from sticking together and developing blood clots. Platelets are small cells in the blood that clump together to form clots, which can be essential for stopping bleeding after an injury. However, in certain situations, such as in the heart or brain arteries, clots can form and block blood flow, leading to severe medical conditions like heart attacks or strokes. Antiplatelet drugs interrupt with the process of platelet aggregation, making it more challenging to stick together and form clots. They are commonly prescribed to individuals at risk of cardiovascular events, particularly those with conditions such as coronary artery disease, atrial fibrillation, or a history of strokes or heart attacks. The first well-known antiplatelet drug is aspirin. It is a cyclooxygenase inhibitor.
Other common antiplatelet medications include clopidogrel, ticagrelor, and prasugrel, which are also widely used. Clopidogrel is commonly prescribed to individuals who have had a recent heart attack stroke or have certain types of chest pain (angina). It works by blocking a specific receptor on the surface of platelets, preventing them from sticking together and forming clots. Ticagrelor is another antiplatelet drug used to prevent blood clots in individuals with acute coronary syndrome (ACS) or a past record of heart attack. It works by blocking another receptor on platelets, effectively preventing them from aggregating. Prasugrel is mostly used in individuals who have undergone a procedure to open up blocked arteries (like angioplasty) or those who have had a heart attack. It acts similarly to clopidogrel but is more powerful and acts more quickly.
FutureWise Market Research has published a report that provides an insightful analysis antiplatelet market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts antiplatelet market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.